Archives
-
SmD2 Acetylation Links Splicing to PARP Sensitivity
2026-09-30
The reference study identifies SmD2 acetylation as a regulatory link between core spliceosome stability, BRCA1/FANC cassette-exon usage, DNA-damage repair, and PARP-inhibitor response in hepatocellular carcinoma. Its mechanistic and in vivo data support combined HDAC and PARP inhibition as a preclinical strategy, while also defining important limits for translating the findings beyond HCC.
-
Promethazine HCl Research Workflows
2026-09-29
Promethazine HCl supports controlled studies of H1 receptor antagonism, histamine-linked inflammation, and macrophage defense. This guide translates product handling and recent ROS/autophagy findings into practical assay designs, controls, and troubleshooting strategies without overstating class-level evidence as compound-specific proof.
-
L-Threonine: Mechanism and Research Workflows
2026-09-29
L-Threonine, also known as (2S,3R)-2-amino-3-hydroxybutanoic acid, is an essential proteinogenic amino acid that links protein synthesis with central carbon metabolism. Its defined identity, water solubility, storage requirements, and use in cell culture optimization make it a practical reagent for metabolic profiling and nutritional intervention studies.
-
Cabazitaxel (XRP6258): Practical Resistant-Model Guide
2026-09-28
Cabazitaxel (XRP6258, SKU B2157) is a water-insoluble semi-synthetic taxane derivative for cell-based antiproliferative studies, including models with P-glycoprotein expression or taxane resistance. This guide covers solvent selection, stock preparation, exposure planning, controls, and QC while limiting conclusions to the product dossier and validated laboratory workflows.
-
AP20187 for Cell Assays: Controls and Protocol
2026-09-28
Learn how to use AP20187 (SKU B1274) as an inducible dimerizer in cell-based proliferation and viability workflows without mistaking it for a direct viability reagent. The guide covers construct compatibility, controls, preparation, interpretation, and practical product-selection criteria.
-
Fibroblast mRNA Delivery for Disc Degeneration
2026-09-27
The study engineers fibroblasts with lipid nanoparticle-delivered mRNA encoding a TNF-α-neutralizing antibody, combining cell-based delivery with local inflammatory control in intervertebral disc degeneration. In cell experiments and a rat model, the approach reduced inflammatory damage and improved disc-related outcomes, although further work is needed to establish durability, safety, and clinical relevance.
-
Apigenin Workflows for Cancer and Neuroprotection
2026-09-26
Use Apigenin to build complementary workflows for malignant mesothelioma growth inhibition and neuroprotection research, with readouts matched to each model rather than assuming a single mechanism. Practical guidance covers dosing, solvent controls, network-guided Alzheimer’s assays, and common sources of experimental variability.
-
KX2-391 Dihydrochloride in HPV Pathway Research
2026-09-25
Explore how KX2-391 dihydrochloride may influence HPV-associated cancer pathways, beyond its established Src and tubulin activities. A close reading of a 2024 HeLa study shows how to design stronger follow-up assays while separating measured protein changes from proposed mechanisms.
-
BPN-19186 for Cell Viability Assay Design
2026-09-25
Learn how to use BPN-19186 (SKU A8959) thoughtfully in viability and osteoclastogenesis workflows, with practical guidance on solubility, controls, and interpretation. The article distinguishes product specifications from published sEH–Nrf2 findings and highlights the validation needed before attributing a cell response to a specific mechanism.
-
2'3'-cGAMP: From STING to Macrophage Reprogramming
2026-09-24
How direct STING activation with 2'3'-cGAMP can help translational researchers connect innate immune signaling to macrophage function—and design more informative cancer immunotherapy studies.
-
AM251: A CB1 Receptor Antagonist for Pain Research
2026-09-24
Use AM251 to test whether CB1 signaling contributes to cannabinoid-linked changes in pain, neuronal activity, or behavior—not to assume that receptor involvement from a single drug comparison. This workflow connects a recent cannabidiol pain study with practical controls, assay choices, and formulation guidance for cannabinoid receptor research.
-
Ceftolozane Sulfate: Assay and PK/PD Workflows
2026-09-23
Build a practical workflow for measuring Ceftolozane activity, from broth microdilution to time-kill and animal PK/PD studies. The guide highlights how to interpret results against Pseudomonas aeruginosa while keeping the research compound distinct from clinical ceftolozane/tazobactam regimens.
-
Halazone: From Water Redox to Nerve Biophysics
2026-09-23
Halazone is an antimicrobial sulfonamide derivative whose chemistry connects rapid water disinfection with experimentally useful membrane redox biology. This evidence-focused guide explains how to interpret its bactericidal activity, sodium-current effects, stability, and cross-domain limitations.
-
TBK1, Microglial Pyroptosis, and Diabetic Neuropathy
2026-09-22
Liao et al. identify TANK-binding kinase 1 (TBK1) as an upstream driver of painful diabetic neuropathy through a microglial NF-κB–NLRP3 pyroptosis pathway. Their combination of genetic knockdown, pharmacological inhibition, behavioral testing, and tissue analysis provides a mechanistic framework for evaluating neuroimmune interventions in diabetes research.
-
AMD-070 Hydrochloride: CXCR4 Antagonist Research
2026-09-22
AMD-070 hydrochloride is the hydrochloride salt of mavorixafor, an oral CXCR4 antagonist that blocks CXCR4/CXCL12 signaling. This research guide separates product specifications from evidence in WHIM syndrome, Waldenström macroglobulinemia, and anti-HIV research.